Literature DB >> 24994093

Endovascular management of intracranial atherosclerosis.

Mohamed S Teleb1, Kaiz Asif1, Alicia C Castonguay1, Osama O Zaidat2.   

Abstract

Intracranial atherosclerotic disease (ICAD) represents one of the most common causes of ischemic stroke worldwide, yet our understanding remains limited regarding the best treatment options for this complex disease with a high recurrence rate of stroke. Although medical therapy has proved to be effective in lowering the risk of stroke, certain high-risk ICAD patients may derive benefit from endovascular therapy. This review presents the current treatment options for the endovascular management of ICAD and highlights the recent relevant literature.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angioplasty; Endovascular; Intracranial atherosclerotic disease; Percutaneous transluminal angioplasty and stenting; Stenosis; Stenting; Stroke

Mesh:

Year:  2014        PMID: 24994093     DOI: 10.1016/j.nec.2014.04.014

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  3 in total

Review 1.  Endovascular Therapy for Symptomatic Intracranial Artery Stenosis: a Systematic Review and Network Meta-analysis.

Authors:  Tao Wang; Kun Yang; Xiao Zhang; Jichang Luo; Ran Xu; Xue Wang; Yutong Yang; Xuesong Bai; Yan Ma; Yuxiang Yan; Liqun Jiao
Journal:  Transl Stroke Res       Date:  2022-02-12       Impact factor: 6.800

Review 2.  Spanning from the West to East: An Updated Review on Endovascular Treatment of Intracranial Atherosclerotic Disease.

Authors:  Mohammed Hussain; Neil Datta; Zhe Cheng; David Dornbos; Asif Bashir; Ibrahim Sultan; Tapan Mehta; Faris Shweikeh; Paul Mazaris; Nora Lee; Amre Nouh; Xiaokun Geng; Yuchuan Ding
Journal:  Aging Dis       Date:  2017-04-01       Impact factor: 6.745

3.  Endovascular treatment for symptomatic intracranial artery stenosis: protocol for a systematic review and network meta-analysis.

Authors:  Tao Wang; Xue Wang; Kun Yang; Jing Zhang; Jichang Luo; Peng Gao; Yan Ma; Liqun Jiao; Feng Ling
Journal:  BMJ Open       Date:  2018-07-10       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.